Abegão Matias Alexandra, Sabino Teresa, Silva-Nunes José
Endocrinol Diabetes Metab Case Rep. 2025 Apr 7;2025(2). doi: 10.1530/EDM-25-0016. Print 2025 Apr 1.
Horner's syndrome is a rare condition that results from damage to the oculosympathetic chain. The classical presentation consists of miosis, unilateral ptosis and hemifacial anhidrosis due to a deficiency of sympathetic activity. Although it has been described as a result of different types of trauma, we present the first clinical report of Horner's syndrome that was developed after a fine-needle aspiration puncture of a thyroid nodule. A 48-year-old woman with a non-toxic multinodular goiter underwent an ultrasound-guided fine-needle aspiration for the second time for a nodule located at the right thyroid lobe. Four hours after the procedure, she developed homolateral eyelid ptosis, miosis and enophthalmos and went to the emergency department for observation. Structural causes potentially related to the manifestations were excluded. Horner's syndrome was diagnosed and the patient was discharged with symptomatic measures. Three months after the event, the patient reported partial improvement. We discuss the pathophysiology associated with Horner's syndrome, the association with thyroid diagnostic and therapeutic procedures, clinical presentation, patient management and prognosis. Although fine-needle aspiration of a thyroid nodule has few associated complications, Horner's syndrome should be considered when the patient develops ophthalmologic symptoms. Preventive measures should be observed to minimize its occurrence.
Horner's syndrome is a potential complication of diagnostic and therapeutic procedures directed at the thyroid gland, including ultrasound-guided fine-needle aspiration. It is characterized by eyelid ptosis, miosis, enophthalmos and anhidrosis homolateral to the lesion. The diagnosis of Horner's syndrome is clinical after excluding structural causes and establishing the temporal relationship between the procedure and the manifestations. There is no targeted treatment for Horner's syndrome, but it can be prevented.
霍纳综合征是一种罕见疾病,由眼交感神经链受损引起。典型表现为由于交感神经活动不足导致的瞳孔缩小、单侧上睑下垂和半侧面部无汗。尽管它已被描述为不同类型创伤的结果,但我们报告了首例甲状腺结节细针穿刺后发生霍纳综合征的临床病例。一名患有非毒性多结节性甲状腺肿的48岁女性,因右侧甲状腺叶的一个结节第二次接受超声引导下细针穿刺。穿刺术后4小时,她出现同侧眼睑下垂、瞳孔缩小和眼球内陷,并前往急诊科观察。排除了与这些表现潜在相关的结构性病因。诊断为霍纳综合征,患者采取对症措施后出院。事件发生三个月后,患者报告症状部分改善。我们讨论了与霍纳综合征相关的病理生理学、与甲状腺诊断和治疗程序的关联、临床表现、患者管理及预后。尽管甲状腺结节细针穿刺的相关并发症较少,但当患者出现眼科症状时应考虑霍纳综合征。应采取预防措施以尽量减少其发生。
霍纳综合征是针对甲状腺的诊断和治疗程序(包括超声引导下细针穿刺)的潜在并发症。其特征为病变同侧的眼睑下垂、瞳孔缩小、眼球内陷和无汗。排除结构性病因并确定程序与表现之间的时间关系后,霍纳综合征的诊断为临床诊断。霍纳综合征没有针对性的治疗方法,但可以预防。